• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟氧头孢在新生儿及早产儿中的药代动力学与临床研究

[Pharmacokinetic and clinical studies on flomoxef in neonates and premature infants].

作者信息

Akita H, Sato Y, Iwata S, Sunakawa K, Yokota T

机构信息

Department of Pediatrics, Yamato City Hospital.

出版信息

Jpn J Antibiot. 1991 Nov;44(11):1240-9.

PMID:1784074
Abstract

Studies were made on pharmacokinetics, clinical effects and influence on intestinal bacterial flora in neonates upon administration of flomoxef (FMOX), and the results obtained are summarized as follows: 1. Serum concentrations of FMOX after intravenous administration of 20 mg/kg/dose were 48.5 micrograms/ml in 30 minutes, 33.0 micrograms/ml in 1 hour and 7.3 micrograms/ml in 6 hours. The T 1/2 was 2.7 hours. FMOX at a dose of 40 mg/kg was given to only one new born baby on the 1st day after birth, and serum concentrations were 73.6 micrograms/ml in 30 minutes, 55.9 micrograms/ml in 1 hour and 16.9 micrograms/ml in 6 hours. The T 1/2 was 4.60 hours. 2. FMOX was administered to 21 neonates between 0 and 32 days of age. Clinical effects were evaluable in 8 of 21 cases. The results were excellent in 2 cases, good in 5 cases and poor in 1 case. Of the 21 cases, diarrhea in 1 case, elevation of eosinophile in 2 cases (9.5%), elevation of platelet count in 3 cases (14.3%), and elevation of GOT in 2 cases (9.5%) were recognized during treatment. 3. FMOX was detected in feces at levels of 0.84-44.4 micrograms/g. Except for a slight decrease in numbers of anaerobes, little fluctuations of intestinal flora were observed during treatment.

摘要

对新生儿使用氟氧头孢(FMOX)后的药代动力学、临床效果及对肠道菌群的影响进行了研究,结果总结如下:1. 静脉注射20mg/kg/剂量后,30分钟时FMOX血清浓度为48.5微克/毫升,1小时时为33.0微克/毫升,6小时时为7.3微克/毫升。半衰期为2.7小时。仅对1例出生第1天的新生儿给予40mg/kg的剂量,30分钟时血清浓度为73.6微克/毫升,1小时时为55.9微克/毫升,6小时时为16.9微克/毫升。半衰期为4.60小时。2. 对21例0至32日龄的新生儿给予FMOX。21例中有8例可评估临床效果。结果为优2例,良5例,差1例。21例中,治疗期间有1例出现腹泻,2例(9.5%)嗜酸性粒细胞升高,3例(14.3%)血小板计数升高,2例(9.5%)谷草转氨酶升高。3. 在粪便中检测到FMOX的水平为0.84 - 44.4微克/克。除厌氧菌数量略有减少外,治疗期间肠道菌群几乎没有波动。

相似文献

1
[Pharmacokinetic and clinical studies on flomoxef in neonates and premature infants].氟氧头孢在新生儿及早产儿中的药代动力学与临床研究
Jpn J Antibiot. 1991 Nov;44(11):1240-9.
2
[Pharmacokinetic and clinical studies on flomoxef in mature and premature infant].氟氧头孢在足月儿和早产儿中的药代动力学及临床研究
Jpn J Antibiot. 1991 Nov;44(11):1294-302.
3
[Flomoxef in neonates and young infants; clinical efficacy, pharmacokinetic evaluation and effect on the intestinal bacterial flora].
Jpn J Antibiot. 1991 Nov;44(11):1216-27.
4
[Clinical evaluation of flomoxef in neonatal infections].氟莫西芬用于新生儿感染的临床评估
Jpn J Antibiot. 1991 Nov;44(11):1286-93.
5
[Pharmacokinetics and clinical studies on flomoxef in neonates and premature infants. A study of flomoxef in the perinatal collaboration research group].氟氧头孢在新生儿和早产儿中的药代动力学及临床研究。围产期协作研究组关于氟氧头孢的一项研究
Jpn J Antibiot. 1993 Jul;46(7):518-38.
6
[Pharmacokinetics and clinical efficacy of flomoxef in neonates].氟氧头孢在新生儿中的药代动力学及临床疗效
Jpn J Antibiot. 1991 Nov;44(11):1228-39.
7
[Pharmacokinetic and clinical studies on aztreonam in neonates and premature infants].氨曲南在新生儿和早产儿中的药代动力学及临床研究
Jpn J Antibiot. 1990 Mar;43(3):413-23.
8
[Pharmacokinetic and clinical evaluations of flomoxef in neonates].氟氧头孢在新生儿中的药代动力学及临床评价
Jpn J Antibiot. 1991 Nov;44(11):1259-64.
9
[Laboratory and clinical studies on flomoxef in neonates and premature infants].氟氧头孢在新生儿及早产儿中的实验室与临床研究
Jpn J Antibiot. 1993 Jul;46(7):547-67.
10
[Laboratory and clinical evaluations of flomoxef sodium in neonates].
Jpn J Antibiot. 1991 Nov;44(11):1265-85.

引用本文的文献

1
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.氟莫头孢治疗新生儿:为产 ESBL 肠杆菌科导致的新生儿败血症治疗提供更多选择。
J Antimicrob Chemother. 2022 Feb 23;77(3):711-718. doi: 10.1093/jac/dkab468.
2
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.用于治疗多重耐药菌引起的新生儿败血症的潜在抗生素
Paediatr Drugs. 2021 Sep;23(5):465-484. doi: 10.1007/s40272-021-00465-z. Epub 2021 Aug 26.